Login / Signup
A new paper from a very large ongoing observational study offers additional and more powerful evidence that dramatic reductions in salt consumption may not be…
No, A Big NIH Trial Did Not Show That Lowering Blood Pressure Will Prevent Dementia
It’s “breakthrough” time again. News reports out of the Alzheimer’s Association International Conference (AAIC) this week have been relentlessly upbeat and positive about findings from the…
If You Look For Atrial Fibrillation You Will Find Atrial Fibrillation
If you look hard to find people who have atrial fibrillation (AF) you will in fact find people who have atrial fibrillation, a new paper published…
Salt War Opponents Unite In Call For Randomized Trial In Prisons
The opposing camps in the salt wars don’t agree on much, but they have now found common ground in their belief that the only way…
More Controversy Over Major Cardiology Clinical Trial
Think about this: A new article reports that a major NIH-funded trial runs into trouble. The article raises all sorts of fundamental questions about our…
Cardiology World Erupts Into Controversy Over Change In Major Clinical Trial
As a major clinical trial in cardiology nears completion it has provoked a storm of criticism and controversy. The brouhaha erupted in response to a…
The ODYSSEY Trial Ends Well— But Will It Be Enough?
Sanofi and Regeneron achieved a modest victory with the much anticipated ODYSSEY Outcomes trial of its cholesterol lowering drug Praluent (alirocumab). The trial met its…
Esperion Releases Top Line Results For First Pivotal Phase 3 Study
Esperion announced positive results today for the first in a series of pivotal phase 3 studies of its cholesterol lowering drug. The trial (Study 4,…
Low-Carb And Low-Fat Diets Battle To A Draw
A new study comparing a low-carbohydrate diet with a low-fat diet found no important differences in weight loss or other important outcomes between the two…
Moment Of Truth For Struggling And Expensive Cholesterol Drugs
It will be the moment of truth for the expensive new cholesterol drugs known as PCSK9 inhibitors. Next month we will learn much more about…